- $1.10bn
- $9.31bn
- $662.89m
- 66
- 81
- 81
- 90
C2019 December 31st | 2020 December 31st | C2021 December 31st | C2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 808 | 178 | 468 | 192 | 663 |
Cost of Revenue | |||||
Gross Profit | 475 | -90.4 | 347 | -67.1 | 234 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 430 | 858 | 136 | 424 | 581 |
Operating Profit | 378 | -679 | 332 | -232 | 81.7 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 378 | -679 | 332 | -232 | 80.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 378 | -679 | 329 | -232 | 80.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 378 | -679 | 329 | -232 | 80.2 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 371 | -709 | 312 | -265 | 47.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.11 | -2.26 | 2.15 | -2.73 | 0.389 |
Dividends per Share |